Favrille Reports Fourth Quarter and Year End 2006 Financial Results
Favrille Announces Agreement With Berlex, Inc. Regarding Use of FavId(R) in Combination With Leukine(R) (sargramostim) in B-Cell Non-Hodgkin's Lymphoma
TargeGen Announces Successful Completion of Phase I Clinical Trial Of Topical AMD Drug TG100801
Home | Our Team | Our Approach | Our Investments | Recent News | Contact Us
Copyright © 2008 Chicago Growth Partners. All rights reserved.
